Columbia Partners Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-12,488
Closed -$904K 211
2018
Q1
$904K Sell
12,488
-1,170
-9% -$89.1K 0.12% 187
2017
Q4
$1.03M Buy
13,658
+2,125
+18% +$160K 0.14% 162
2017
Q3
$887K Sell
11,533
-6,013
-34% -$454K 0.12% 168
2017
Q2
$1.31M Buy
17,546
+583
+3% +$41.3K 0.17% 167
2017
Q1
$1.13M Buy
16,963
+1,830
+12% +$122K 0.14% 175
2016
Q4
$987K Sell
15,133
-330
-2% -$21.4K 0.09% 234
2016
Q3
$1.09M Buy
15,463
+198
+1% +$14.4K 0.09% 232
2016
Q2
$1.13M Buy
15,265
+402
+3% +$27.8K 0.08% 259
2016
Q1
$964K Buy
14,863
+866
+6% +$58.9K 0.07% 276
2015
Q4
$1.08M Sell
13,997
-984
-7% -$78.2K 0.07% 241
2015
Q3
$1.23M Sell
14,981
-1,299
-8% -$116K 0.09% 226
2015
Q2
$1.43M Buy
16,280
+968
+6% +$88.8K 0.09% 215
2015
Q1
$1.35M Sell
15,312
-19,940
-57% -$1.77M 0.07% 217
2014
Q4
$2.93M Sell
35,252
-12,180
-26% -$1.01M 0.15% 175
2014
Q3
$4M Buy
47,432
+2,917
+7% +$236K 0.2% 147
2014
Q2
$3.61M Buy
44,515
+31,545
+243% +$2.48M 0.17% 174
2014
Q1
$988K Sell
12,970
-8,584
-40% -$625K 0.04% 263
2013
Q4
$1.55M Sell
21,554
-16,410
-43% -$1.14M 0.07% 213
2013
Q3
$2.61M Sell
37,964
-10,738
-22% -$710K 0.12% 194
2013
Q2
$3.08M Buy
+48,702
New +$3.17M 0.15% 184

Other funds holding NVS

Columbia Partners Investment Management's NVS Position: Q2 2018 in Review

Columbia Partners Investment Management sold out of Novartis (NVS) in Q2 2018, closing a stake of 12,488 shares — an estimated $904K sold.

Columbia Partners Investment Management first reported a position in NVS in Q2 2013 and held it in 20 quarters. The position peaked at $4M in Q3 2014. 988 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

  • Columbia Partners Investment Management reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
  • Columbia Partners Investment Management sold 12,488 Novartis shares in Q2 2018, an estimated $904K.
  • Columbia Partners Investment Management first reported a position in Novartis in Q2 2013 and held it in 20 quarters.
  • Columbia Partners Investment Management's Novartis position peaked at $4M in Q3 2014.
  • 988 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Columbia Partners Investment Management's 13F filing for Q2 2018, filed 12 Jul 2018.